查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1492306

线上药局市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2032

ePharmacy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球线上药局市场的综合报告，提供了关键市场动态、成长动力/课题和新兴趋势的宝贵见解。本报告提供了独家数据和统计数据，详细概述了线上药局格局，并预测了 2024 年至 2032 年的市场成长轨迹。

重要见解

  • 线上药局市场规模（2024年）：1,194亿美元
  • 预计市值（2032年）：5,694亿美元
  • 全球市场成长率（复合年增长率，2024-2032）：21.6%

线上药局市场 - 报告范围：

由于越来越多地采用数位平台购买药品，线上药局市场正在强劲成长。网路药局为消费者取得处方药和非处方药提供了方便、便捷且经济高效的解决方案。该市场为包括患者、护理人员和医疗保健提供者在内的多元化客户群提供服务，并提供各种药品和保健品。电子商务技术的进步、互联网普及率的提高以及人们对网上购物的日益偏好正在推动市场成长。

市场成长动力：

全球线上药局市场受益于几个关键的成长动力。慢性病的流行和人口老化正在推动药品需求并支持市场扩张。电子商务的技术进步，例如用户友好的网站、行动应用程式和安全支付网关，改善了消费者体验并促进了市场成长。此外，随着消费者寻求更安全、非接触式的方式获取药物，COVID-19 的爆发加速了线上药局的采用。送货上门的便利性、丰富的产品选择以及具有竞争力的价格进一步促进了市场的成长。

市场限制因素：

儘管成长前景广阔，但线上药局市场仍面临监管合规、网路安全和竞争等方面的课题。关于线上药品销售的严格规定因地区而异，给线上药局经营者带来了合规课题。此外，对资料安全、隐私和假药风险的担忧也会影响消费者信任和市场渗透。竞争格局非常激烈，随着传统药局扩大其线上业务以及新进业者不断涌现，线上药局面临越来越大的压力，要求其产品差异化并保持客户忠诚度。解决这些障碍需要在监管合规性、网路安全措施和创新的客户参与策略方面进行投资。

市场机会：

线上药局市场透过技术创新、市场多元化和策略合作伙伴关係提供了巨大的成长机会。远距医疗整合、个人化医疗和人工智慧驱动的健康解决方案等新兴趋势为线上药局增强其价值主张提供了新途径。透过扩大我们的产品组合，包括健康产品、医疗器材和健康服务，我们可以吸引更广泛的客户。此外，与医疗保健提供者、保险公司和製药公司的策略联盟使我们能够扩大市场覆盖范围、改善服务交付并推动客户获取。此外，对行销、客户教育和忠诚度计划的投资可以增强品牌影响力和消费者参与度。

目录

第一章执行摘要

第2章 市场概况

  • 市场范围/分类
  • 市场定义/范围/限制

第三章 市场风险与趋势评估

  • 风险评估
    • COVID-19 危机及其对线上药局需求的影响
    • 与过去的危机相比，对 COVID-19 的影响进行基准测试
    • 对市场价值的影响
    • 评价：依主要国家划分
    • 评估：依主要细分市场
    • 对供应商的行动要点和建议
  • 影响市场的主要趋势
  • 配方和产品开发趋势

第四章 市场背景及基本数据点

  • 全球网路药局市场
  • 线上药局市场机会评估
    • 可占领的最大市场规模
    • 可服务的可寻址市场规模
    • 可服务的可占领市场规模
  • 市集情境预测
    • 乐观情况下的需求
    • 预期场景的需求
    • 保守情境的需求
  • 投资可行性分析
    • 投资成熟市场
    • 投资新兴市场
  • 预测变量 - 相关性和影响
    • 顶尖公司的历史成长
    • 全球线上药局市场的成长
    • 网路药局采用率：依国家分类
  • 市场动态
    • 市场驱动因素与影响评估
    • 主要市场课题和影响评估
    • 网路药局市场机会
    • 世界市场的重要趋势及其影响评估

第 5 章关键成功因素

  • 製造商专注于渗透率低但成长率高的市场
  • 押注于您所在细分市场的高增量机会
  • 同行基准

第六章全球网路药局市场需求分析

  • 历史市场分析，2019-2023
  • 目前和未来的市场预测，2024-2032
  • 同比增长趋势分析

第七章 全球线上药局市场价值分析

  • 2019-2023年历史市值分析
  • 当前和未来市场价值预测，2024-2032
    • 同比增长趋势分析
    • 绝对量机会分析

第八章全球线上药局市场分析：依药局类型

  • 简介/主要发现
  • 历史市场规模分析：依药局类型，2019-2023
  • 当前和未来市场规模的分析和预测：依药房类型，2024-2032
    • 大
    • 中
    • 小的
  • 市场吸引力分析：依药局类型

第九章全球线上药局市场分析：依地区

  • 介绍
  • 历史市场规模分析：依地区划分，2019-2023
  • 目前市场规模/分析与预测：依地区划分，2024-2032
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东和非洲 (MEA)
  • 市场吸引力分析：依地区

第十章北美线上药局市场分析

第十一章拉丁美洲线上药局市场分析

第十二章欧洲线上药局市场分析

第十三章亚太线上药局市场分析

第十四章中东与非洲网路药局市场分析

第十五章 主要国家网路药局市场分析

  • 介绍
    • 市值比分析：以主要国家
    • 世界与国家成长比较
  • 美国网路药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 加拿大网路药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 墨西哥网上药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 巴西网上药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 德国网路药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 法国网上药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 义大利网路药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 比荷卢线上药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 英国网路药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 北欧国家网路药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 中国网上药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 日本网路药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 韩国网路药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 海湾合作委员会国家线上药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 南非线上药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
  • 土耳其网上药局市场分析
    • 价值比率分析：依市场分类
    • 金额/分析与预测：依市场分类，2019-2032
    • 国内竞争格局及企业集中度

第16章市场结构分析

  • 市场分析：依公司层级
  • 市场集中度
  • 主要参与者的市场占有率分析
  • 市场存在分析

第 17 章 竞争分析

  • 比赛仪表板
  • 竞争标桿
  • 竞争对手详情
    • THE KROGER Co.
    • WALGREEN Co.
    • GIANT EAGLE, INC.
    • WALMART, INC.
    • EXPRESS SCRIPTS HOLDING COMPANY
    • CVS HEALTH
    • OPTUM RX, INC.
    • ROWLANDS PHARMACY
    • DOCMORRIS（ZUR ROSE GROUP AG）

第 18 章使用的假设和首字母缩略词

第19章研究方法论

简介目录
Product Code: PMRREP16273

Persistence Market Research, a renowned market research firm, has recently published a comprehensive report on the global ePharmacy Market, offering valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. This report provides an in-depth overview of the ePharmacy landscape, presenting exclusive data and statistics forecasting the market's growth trajectory from 2024 to 2032.

Key Insights:

  • ePharmacy Market Size (2024): US$119.4 Bn
  • Projected Market Value (2032): US$569.4 Bn
  • Global Market Growth Rate (CAGR 2024 to 2032):21.6%

ePharmacy Market - Report Scope:

The ePharmacy market is witnessing robust growth, driven by the increasing adoption of digital platforms for purchasing pharmaceuticals. ePharmacies provide a convenient, accessible, and cost-effective solution for consumers to obtain prescription and over-the-counter medications. This market serves a diverse customer base, including patients, caregivers, and healthcare providers, offering a wide range of pharmaceutical products and health supplements. Market growth is fueled by advancements in e-commerce technology, rising internet penetration, and a growing preference for online shopping.

Market Growth Drivers:

The global ePharmacy market benefits from several key growth drivers. The increasing prevalence of chronic diseases and the aging population drive demand for medications, supporting market expansion. Technological advancements in e-commerce, such as user-friendly websites, mobile applications, and secure payment gateways, enhance the consumer experience and boost market growth. Moreover, the COVID-19 pandemic has accelerated the adoption of ePharmacies, as consumers seek safer, contactless options for obtaining medications. The convenience of home delivery, availability of a wide product range, and competitive pricing further contribute to the market's growth.

Market Restraints:

Despite its promising growth prospects, the ePharmacy market faces challenges related to regulatory compliance, cybersecurity, and competition. Strict regulations governing the sale of pharmaceuticals online vary across regions, posing compliance challenges for ePharmacy operators. Additionally, concerns about data security, privacy, and the risk of counterfeit medications impact consumer trust and market penetration. The competitive landscape is intense, with traditional pharmacies expanding their online presence and new entrants entering the market, increasing the pressure on ePharmacies to differentiate their offerings and maintain customer loyalty. Addressing these barriers requires investment in regulatory compliance, cybersecurity measures, and innovative customer engagement strategies.

Market Opportunities:

The ePharmacy market presents significant growth opportunities driven by technological innovations, market diversification, and strategic partnerships. Emerging trends such as telemedicine integration, personalized medicine, and AI-driven health solutions offer new avenues for ePharmacies to enhance their value proposition. Expanding product portfolios to include wellness products, medical devices, and health services can attract a broader customer base. Furthermore, strategic collaborations with healthcare providers, insurers, and pharmaceutical companies can enhance market reach, improve service offerings, and drive customer acquisition. Investment in marketing, customer education, and loyalty programs can also strengthen brand presence and consumer engagement.

Competitive Intelligence and Business Strategy:

Leading players in the global ePharmacy market, including [Insert Key Companies], focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in advanced e-commerce technologies, secure payment solutions, and efficient logistics to enhance the customer experience. Collaborations with healthcare providers, pharmaceutical manufacturers, and insurers enable companies to offer integrated healthcare solutions and improve market penetration. Moreover, emphasis on regulatory compliance, data security, and customer service fosters market growth and enhances consumer trust in the dynamic ePharmacy landscape.

Key Companies Profiled:

  • THE KROGER Co.
  • WALGREEN Co.
  • GIANT EAGLE, INC.
  • WALMART, INC.
  • EXPRESS SCRIPTS HOLDING COMPANY
  • CVS HEALTH
  • OPTUM RX, INC.
  • ROWLANDS PHARMACY
  • DOCMORRIS (ZUR ROSE GROUP AG)

ePharmacy Market Research Segmentation:

By Pharmacy Size

  • Large
  • Medium
  • Small

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Summary of Statistics
  • 1.3. Key Market Characteristics & Attributes
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

  • 3.1. Risk Assessment
    • 3.1.1. COVID-19 Crisis and Impact on ePharmacy Demand
    • 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
    • 3.1.3. Impact on Market Value (US$ Bn)
    • 3.1.4. Assessment by Key Countries
    • 3.1.5. Assessment by Key Market Segments
    • 3.1.6. Action Points and Recommendation for Suppliers
  • 3.2. Key Trends Impacting the Market
  • 3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

  • 4.1. Global ePharmacy Market (US$ Bn)
  • 4.2. ePharmacy Market Opportunity Assessment (US$ Bn)
    • 4.2.1. Total Available Market
    • 4.2.2. Serviceable Addressable Market
    • 4.2.3. Serviceable Obtainable Market
  • 4.3. Market Scenario Forecast
    • 4.3.1. Demand in optimistic Scenario
    • 4.3.2. Demand in Likely Scenario
    • 4.3.3. Demand in Conservative Scenario
  • 4.4. Investment Feasibility Analysis
    • 4.4.1. Investment in Established Markets
      • 4.4.1.1. In Short Term
      • 4.4.1.2. In Long Term
    • 4.4.2. Investment in Emerging Markets
      • 4.4.2.1. In Short Term
      • 4.4.2.2. In Long Term
  • 4.5. Forecast Factors - Relevance & Impact
    • 4.5.1. Top Companies Historical Growth
    • 4.5.2. Global ePharmacy Market Growth
    • 4.5.3. ePharmacy Adoption Rate, by Country
  • 4.6. Market Dynamics
    • 4.6.1. Market Driving Factors and Impact Assessment
    • 4.6.2. Prominent Market Challenges and Impact Assessment
    • 4.6.3. ePharmacy Market Opportunities
    • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

  • 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
  • 5.2. Banking on with Segments High Incremental Opportunity
  • 5.3. Peer Benchmarking

6. Global ePharmacy Market Demand Analysis 2019-2023 and Forecast, 2024-2032

  • 6.1. Historical Market Analysis, 2019-2023
  • 6.2. Current and Future Market Projections, 2024-2032
  • 6.3. Y-o-Y Growth Trend Analysis

7. Global ePharmacy Market Value Analysis 2019-2023 and Forecast, 2024-2032

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global ePharmacy Market Analysis 2019-2023 and Forecast 2024-2032, By Pharmacy Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Pharmacy Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Pharmacy Type, 2024-2032
    • 8.3.1. Large
    • 8.3.2. Middle
    • 8.3.3. Small
  • 8.4. Market Attractiveness Analysis By Pharmacy Type

9. Global ePharmacy Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 9.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2032
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. Asia Pacific
    • 9.3.5. Middle East and Africa (MEA)
  • 9.4. Market Attractiveness Analysis By Region

10. North America ePharmacy Market Analysis 2019-2023 and Forecast 2024-2032

  • 10.1. Introduction
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
    • 10.4.1. By Country
      • 10.4.1.1. U.S.
      • 10.4.1.2. Canada
    • 10.4.2. By Pharmacy Type
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Country
    • 10.5.2. By Pharmacy Type

11. Latin America ePharmacy Market Analysis 2019-2023 and Forecast 2024-2032

  • 11.1. Introduction
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
    • 11.4.1. By Country
      • 11.4.1.1. Brazil
      • 11.4.1.2. Mexico
      • 11.4.1.3. Rest of Latin America
    • 11.4.2. By Pharmacy Type
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Pharmacy Type

12. Europe ePharmacy Market Analysis 2019-2023 and Forecast 2024-2032

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
    • 12.4.1. By Country
      • 12.4.1.1. Germany
      • 12.4.1.2. France
      • 12.4.1.3. U.K.
      • 12.4.1.4. Italy
      • 12.4.1.5. Benelux
      • 12.4.1.6. Nordic Countries
      • 12.4.1.7. Rest of Europe
    • 12.4.2. By Pharmacy Type
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Pharmacy Type

13. Asia Pacific ePharmacy Market Analysis 2019-2023 and Forecast 2024-2032

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
    • 13.4.1. By Country
      • 13.4.1.1. China
      • 13.4.1.2. Japan
      • 13.4.1.3. South Korea
      • 13.4.1.4. Rest of Asia Pacific
    • 13.4.2. By Pharmacy Type
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Pharmacy Type

14. Middle East and Africa ePharmacy Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2032
    • 14.4.1. By Country
      • 14.4.1.1. GCC Countries
      • 14.4.1.2. South Africa
      • 14.4.1.3. Turkey
      • 14.4.1.4. Rest of Middle East and Africa
    • 14.4.2. By Pharmacy Type
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Pharmacy Type

15. Key Countries ePharmacy Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
    • 15.1.1. Market Value Proportion Analysis, By Key Countries
    • 15.1.2. Global Vs. Country Growth Comparison
  • 15.2. US ePharmacy Market Analysis
    • 15.2.1. Value Proportion Analysis by Market Taxonomy
    • 15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.2.2.1. By Pharmacy Type
  • 15.3. Canada ePharmacy Market Analysis
    • 15.3.1. Value Proportion Analysis by Market Taxonomy
    • 15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.3.2.1. By Pharmacy Type
  • 15.4. Mexico ePharmacy Market Analysis
    • 15.4.1. Value Proportion Analysis by Market Taxonomy
    • 15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.4.2.1. By Pharmacy Type
  • 15.5. Brazil ePharmacy Market Analysis
    • 15.5.1. Value Proportion Analysis by Market Taxonomy
    • 15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.5.2.1. By Pharmacy Type
  • 15.6. Germany ePharmacy Market Analysis
    • 15.6.1. Value Proportion Analysis by Market Taxonomy
    • 15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.6.2.1. By Pharmacy Type
  • 15.7. France ePharmacy Market Analysis
    • 15.7.1. Value Proportion Analysis by Market Taxonomy
    • 15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.7.2.1. By Pharmacy Type
  • 15.8. Italy ePharmacy Market Analysis
    • 15.8.1. Value Proportion Analysis by Market Taxonomy
    • 15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.8.2.1. By Pharmacy Type
  • 15.9. BENELUX ePharmacy Market Analysis
    • 15.9.1. Value Proportion Analysis by Market Taxonomy
    • 15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.9.2.1. By Pharmacy Type
  • 15.10. UK ePharmacy Market Analysis
    • 15.10.1. Value Proportion Analysis by Market Taxonomy
    • 15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.10.2.1. By Pharmacy Type
  • 15.11. Nordic Countries ePharmacy Market Analysis
    • 15.11.1. Value Proportion Analysis by Market Taxonomy
    • 15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.11.2.1. By Pharmacy Type
  • 15.12. China ePharmacy Market Analysis
    • 15.12.1. Value Proportion Analysis by Market Taxonomy
    • 15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.12.2.1. By Pharmacy Type
  • 15.13. Japan ePharmacy Market Analysis
    • 15.13.1. Value Proportion Analysis by Market Taxonomy
    • 15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.13.2.1. By Pharmacy Type
  • 15.14. South Korea ePharmacy Market Analysis
    • 15.14.1. Value Proportion Analysis by Market Taxonomy
    • 15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.14.2.1. By Pharmacy Type
  • 15.15. GCC Countries ePharmacy Market Analysis
    • 15.15.1. Value Proportion Analysis by Market Taxonomy
    • 15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.15.2.1. By Pharmacy Type
  • 15.16. South Africa ePharmacy Market Analysis
    • 15.16.1. Value Proportion Analysis by Market Taxonomy
    • 15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.16.2.1. By Pharmacy Type
  • 15.17. Turkey ePharmacy Market Analysis
    • 15.17.1. Value Proportion Analysis by Market Taxonomy
    • 15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 15.17.2.1. By Pharmacy Type
    • 15.17.3. Competition Landscape and Player Concentration in the Country

16. Market Structure Analysis

  • 16.1. Market Analysis by Tier of Companies
  • 16.2. Market Concentration
  • 16.3. Market Share Analysis of Top Players
  • 16.4. Market Presence Analysis
    • 16.4.1. By Regional footprint of Players
    • 16.4.2. Product footprint by Players

17. Competition Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competition Benchmarking
  • 17.3. Competition Deep Dive
    • 17.3.1. THE KROGER Co.
      • 17.3.1.1. Overview
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Sales Footprint
      • 17.3.1.4. Strategy Overview
    • 17.3.2. WALGREEN Co.
      • 17.3.2.1. Overview
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Sales Footprint
      • 17.3.2.4. Strategy Overview
    • 17.3.3. GIANT EAGLE, INC.
      • 17.3.3.1. Overview
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Sales Footprint
      • 17.3.3.4. Strategy Overview
    • 17.3.4. WALMART, INC.
      • 17.3.4.1. Overview
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Sales Footprint
      • 17.3.4.4. Strategy Overview
    • 17.3.5. EXPRESS SCRIPTS HOLDING COMPANY
      • 17.3.5.1. Overview
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Sales Footprint
      • 17.3.5.4. Strategy Overview
    • 17.3.6. CVS HEALTH
      • 17.3.6.1. Overview
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Sales Footprint
      • 17.3.6.4. Strategy Overview
    • 17.3.7. OPTUM RX, INC.
      • 17.3.7.1. Overview
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Sales Footprint
      • 17.3.7.4. Strategy Overview
    • 17.3.8. ROWLANDS PHARMACY
      • 17.3.8.1. Overview
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Sales Footprint
      • 17.3.8.4. Strategy Overview
    • 17.3.9. DOCMORRIS (ZUR ROSE GROUP AG)
      • 17.3.9.1. Overview
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Sales Footprint
      • 17.3.9.4. Strategy Overview

18. Assumptions and Acronyms Used

19. Research Methodology